naringenin has been researched along with Lymphoma, T-Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dos Santos, DJVA; Ferreira, MU; Ferreira, RJ; Gajdács, M; Kincses, A; Spengler, G | 1 |
Ahmad, B; Csonka, A; Jehan, N; Molnar, J; Rauf, A; Raza, M; Siddiqui, BS; Szabo, D; Uddin, G | 1 |
2 other study(ies) available for naringenin and Lymphoma, T-Cell
Article | Year |
---|---|
Nitrogen-containing naringenin derivatives for reversing multidrug resistance in cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Binding Sites; Binding, Competitive; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Euphorbia; Flavanones; Humans; Lymphoma, T-Cell; Mice; Molecular Docking Simulation; Nitrogen; Structure-Activity Relationship | 2020 |
Reversal of Multidrug Resistance in Mouse Lymphoma Cells by Extracts and Flavonoids from Pistacia integerrima.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Line, Tumor; Drug Resistance, Multiple; Flavanones; Flavonoids; Hydrophobic and Hydrophilic Interactions; Lymphoma, T-Cell; Mice; Molecular Docking Simulation; Pistacia; Plant Extracts; Transfection | 2016 |